Patients aren’t joining clinical trials for the small reimbursements they may receive, expert says. “They know their volunteerism can advance science and help others.”
“If our objective [as an industry] is to develop trials with populations that reflect the real world, we must include everyone—it’s a moral and scientific imperative.”
“These initiatives are most welcome as we work together to bridge the gaps in patient care and include more people in beneficial clinical trials.”
With the COVID-19 pandemic far from being conquered across much of the globe but becoming somewhat more manageably endemic in areas, many clinical trials programs once entirely shuttered or retooled for coronavirus vaccine or treatment studies are reverting to more or less normal operations. Among other topics, the forthcoming June issue of Clinical Researcher, ACRP’s […]
“The Latinx population [by and large] still doesn’t understand what clinical trials are, and why they are important. We must do a better job at educating them.”
